The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

BACKGROUND AND AIMS: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are effective against classical EGFR mutations in lung cancer. However, their effectiveness and the prognosis of lung cancer patients with complex EGFR mutations are not well delineated. Therefore, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shang-Gin, Yu, Chong-Jen, Yang, James Chih-Hsin, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Advances in Treatment of Lung Cancer Patients With Targetable Mutations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418472/
https://www.ncbi.nlm.nih.gov/pubmed/32843903
http://dx.doi.org/10.1177/1758835920946156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418472/
https://www.ncbi.nlm.nih.gov/pubmed/32843903
http://dx.doi.org/10.1177/1758835920946156

Ejemplares similares